Balyasny Asset Management
PFE icon

Balyasny Asset Management’s Pfizer PFE Stock Holding History

Balyasny Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.3M Sell
1,362,800
-157,300
-10% -$4.19M 0.05% 429
2025
Q4 		$37.9M Sell
1,520,100
-430,600
-22% -$10.9M 0.05% 445
2025
Q3 		$49.7M Buy
1,950,700
+578,100
+42% +$14.3M 0.06% 367
2025
Q2 		$33.3M Buy
1,372,600
+938,500
+216% +$21.9M 0.05% 463
2025
Q1 		$11M Buy
434,100
+394,400
+993% +$10.3M 0.02% 863
2024
Q4 		$1.05M Sell
39,700
-2,859,100
-99% -$77.6M ﹤0.01% 1930
2024
Q3 		$83.9M Buy
2,898,800
+2,873,500
+11,358% +$83.8M 0.14% 164
2024
Q2 		$708K Sell
25,300
-1,376,400
-98% -$37.9M ﹤0.01% 1923
2024
Q1 		$38.9M Sell
1,401,700
-14,300
-1% -$397K 0.07% 393
2023
Q4 		$40.8M Sell
1,416,000
-4,670,000
-77% -$141M 0.08% 324
2023
Q3 		$202M Buy
6,086,000
+4,695,000
+338% +$166M 0.41% 32
2023
Q2 		$51M Buy
+1,391,000
New +$54.1M 0.11% 247
2022
Q1 		– Sell
-280,000
Closed -$16.5M – 2758
2021
Q4 		$16.5M Buy
+280,000
New +$13.9M 0.06% 489
2021
Q3 		– Sell
-20,000
Closed -$783K – 2313
2021
Q2 		$783K Sell
20,000
-80,000
-80% -$3.11M ﹤0.01% 1394
2021
Q1 		$3.62M Hold
100,000
– – 0.02% 816
2020
Q4 		$3.68M Sell
100,000
-4,959,200
-98% -$182M 0.02% 738
2020
Q3 		$176M Buy
5,059,200
+2,635,000
+109% +$92.4M 1.29% 1
2020
Q2 		$75.2M Buy
+2,424,200
New +$82.4M 0.65% 16
2017
Q4 		– Sell
-1,633,700
Closed -$55.3M – 2243
2017
Q3 		$55.3M Buy
+1,633,700
New +$52.5M 0.22% 111
2015
Q3 		– Sell
-122,053
Closed -$3.88M – 1325
2015
Q2 		$3.88M Sell
122,053
-931,947
-88% -$30.4M 0.02% 649
2015
Q1 		$34.8M Buy
+1,054,000
New +$33.5M 0.28% 99

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Balyasny Asset Management's PFE Position: Q1 2026 in Review

Balyasny Asset Management increased its Pfizer (PFE) stake by 23% in Q1 2026, buying an estimated $51.3M and bringing the position to 10,471,388 shares worth $294M. The position accounts for 0.38% of the portfolio, ranked #34.

Balyasny Asset Management first reported a position in PFE in Q4 2014 and has held it in 41 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Balyasny Asset Management held 10,471,388 shares of Pfizer worth $294M as of Q1 2026.
  • Balyasny Asset Management bought 1,926,496 Pfizer shares in Q1 2026, an estimated $51.3M.
  • Pfizer made up 0.38% of Balyasny Asset Management's portfolio in Q1 2026, its #34 holding.
  • Balyasny Asset Management first reported a position in Pfizer in Q4 2014 and has held it in 41 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.